Ratings by Oppenheimer (Justin Kim)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/20/2026 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/4/2025 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2025 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2025 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2025 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 4/7/2025 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2025 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2025 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2024 | Aldeyra Therapeutics | ALDX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2024 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/14/2024 | Pharvaris B.V. | PHVS | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/3/2024 | Aldeyra Therapeutics | ALDX | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/16/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/6/2024 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/3/2024 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2024 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2024 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2024 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2024 | Aldeyra Therapeutics | ALDX | Upgrade | Outperform (Perform) |
3.55 (2.06) |
-41.97% | Details | |
| 4/1/2024 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2024 | Alpine Immune Sciences | ALPN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/29/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/26/2024 | Alpine Immune Sciences | ALPN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/25/2024 | Vera Therapeutics | VERA | New Coverage | Outperform (N/A) |
17.04 (37.92) |
122.54% | Details | |
| 12/27/2023 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 12/27/2023 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 12/26/2023 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/22/2023 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/15/2023 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/6/2023 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/16/2023 | Aldeyra Therapeutics | ALDX | Downgrade | Perform (Outperform) |
5.43 (3.55) |
-34.62% | Details | |
| 9/21/2023 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 9/11/2023 | Alpine Immune Sciences | ALPN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2023 | Zura Bio Ltd. | ZURA | New Coverage | Outperform (N/A) |
6.97 (3.98) |
-42.9% | Details | |
| 8/11/2023 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2023 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 6/26/2023 | Alpine Immune Sciences | ALPN | New Coverage | Outperform (N/A) |
11.63 (64.97) |
458.64% | Details | |
| 5/12/2023 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2023 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2023 | Chinook Therapeutics | KDNY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/21/2023 | Chinook Therapeutics | KDNY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2023 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 12/14/2022 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2022 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/18/2022 | Provention Bio Inc. | PRVB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Aurinia Pharmaceuticals | AUPH | Downgrade | Perform (Outperform) |
5.18 (17.41) |
236.1% | Details | |
| 8/22/2022 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2022 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2022 | Provention Bio Inc. | PRVB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2022 | Aurinia Pharmaceuticals | AUPH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2022 | BioCryst Pharma | BCRX | Downgrade | Perform (Outperform) |
11.15 (9.15) |
-17.94% | Details | |
| 7/18/2022 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
39.31 (75.78) |
92.78% | Details | |
| 7/12/2022 | Aldeyra Therapeutics | ALDX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/6/2022 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 6/30/2022 | Angion Biomedica | ANGN | Downgrade | Perform (Outperform) |
1.82 (1.00) |
-45.05% | Details | |
| 6/8/2022 | Aldeyra Therapeutics | ALDX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/23/2022 | Chinook Therapeutics | KDNY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2022 | BioCryst Pharma | BCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/29/2022 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 4/11/2022 | BioCryst Pharma | BCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/17/2022 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2022 | Aurinia Pharmaceuticals | AUPH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2022 | BioCryst Pharma | BCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/22/2021 | Cytokinetics | CYTK | New Coverage | Outperform (N/A) |
39.50 (80.24) |
103.14% | Details | |
| 12/10/2021 | Angion Biomedica | ANGN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2021 | Aurinia Pharmaceuticals | AUPH | Upgrade | Outperform (Perform) |
20.83 (17.41) |
-16.42% | Details | |
| 12/10/2021 | BioCryst Pharma | BCRX | New Coverage | Outperform (N/A) |
12.24 (9.15) |
-25.25% | Details | |
| 11/4/2021 | Aurinia Pharmaceuticals | AUPH | Maintain | Perform (N/A) |
|
Details | ||
| 10/28/2021 | Aurinia Pharmaceuticals | AUPH | Downgrade | Perform (Outperform) |
30.35 (17.41) |
-42.64% | Details | |
| 10/27/2021 | Angion Biomedica | ANGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2021 | Immunocore Holdings | IMCR | New Coverage | Outperform (N/A) |
37.61 (28.70) |
-23.69% | Details | |
| 9/10/2021 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2021 | Provention Bio Inc. | PRVB | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2021 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 4/9/2021 | Provention Bio Inc. | PRVB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2021 | Angion Biomedica | ANGN | New Coverage | Outperform (N/A) |
19.92 (1.00) |
-94.98% | Details | |
| 3/2/2021 | Pharvaris B.V. | PHVS | New Coverage | Outperform (N/A) |
39.23 (33.00) |
-15.88% | Details | |
| 1/25/2021 | Aurinia Pharmaceuticals | AUPH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2020 | Chinook Therapeutics | KDNY | Upgrade | Outperform (Perform) |
16.73 (40.39) |
141.42% | Details | |
| 6/8/2020 | Aduro Biotech | ADRO | New Coverage | Perform (N/A) |
2.28 (14.60) |
540.35% | Details | |
| 6/4/2020 | Provention Bio Inc. | PRVB | New Coverage | Outperform (N/A) |
15.00 (24.98) |
66.53% | Details | |
| 5/12/2020 | Aldeyra Therapeutics | ALDX | New Coverage | Outperform (N/A) |
2.85 (2.06) |
-27.72% | Details | |
| 1/8/2020 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2020 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/5/2019 | Aurinia Pharmaceuticals | AUPH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2019 | Aurinia Pharmaceuticals | AUPH | New Coverage | Outperform (N/A) |
5.82 (17.41) |
199.14% | Details | |
| 8/29/2019 | Dova Pharmaceuticals Inc | DOVA | New Coverage | Outperform (N/A) |
14.41 (28.04) |
94.59% | Details |
